Literature DB >> 19909464

Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific.

Catherine W M Ong1, David C B Lye, Kay Leong Khoo, Gerald Seng Wee Chua, Siang Fei Yeoh, Yee Sin Leo, Paul Ananth Tambyah, Arlene Christine Chua.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients with community-acquired Acinetobacter baumannii (AB) pneumonia have been reported from subtropical countries. We investigated the epidemiology, clinical and microbiological characteristics of community-acquired pneumonia (CAP) due to AB in Singapore.
METHOD: A retrospective case series was performed over a 21-month period at two institutions.
RESULTS: From 1 January 2007 to 30 September 2008, eight patients were diagnosed with CAP due to AB. Seven had bacteraemia and five were sputum culture-positive. The median age at presentation was 58.5 years (range 45-76 years). Five patients (71.4%) acquired the pneumonia in the warmer months of June to September. Presentation was acute, with a median duration of 2.5 days (range 1-7 days). The median Acute Physiology and Chronic Health Evaluation II score was 28.5 (range 6-36). Six patients presented with septic shock, lactic acidosis, acute kidney injury and respiratory failure, necessitating ICU care; five of these patients eventually died. All patients received empirical antibiotics, including third-generation cephalosporins, which were inactive against the organism. All isolates were susceptible to ampicillin/sulbactam, ciprofloxacin, co-trimoxazole, aminoglycosides and imipenem.
CONCLUSIONS: Community-acquired AB pneumonia have a fulminant course. In a region endemic for melioidosis and severe community-acquired Klebsiella pneumoniae, the challenge lies in rapid identification and initiation of appropriate empirical antibiotics to improve the survival of patients with AB CAP.

Entities:  

Mesh:

Year:  2009        PMID: 19909464     DOI: 10.1111/j.1440-1843.2009.01630.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  30 in total

1.  Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.

Authors:  Michael J McConnell; Juan Domínguez-Herrera; Younes Smani; Rafael López-Rojas; Fernando Docobo-Pérez; Jerónimo Pachón
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 2.  Signaling Natural Products from Human Pathogenic Bacteria.

Authors:  Zhijuan Hu; Wenjun Zhang
Journal:  ACS Infect Dis       Date:  2019-10-30       Impact factor: 5.084

3.  Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis.

Authors:  Daniel V Zurawski; Mitchell G Thompson; Christin N McQueary; Malcolm N Matalka; Jason W Sahl; David W Craft; David A Rasko
Journal:  J Bacteriol       Date:  2012-03       Impact factor: 3.490

4.  Complete genome sequence of multidrug-resistant Acinetobacter baumannii strain 1656-2, which forms sturdy biofilm.

Authors:  Jin Yeol Park; Shukho Kim; Sung-Min Kim; Sun Ho Cha; Si-Kyu Lim; Jungmin Kim
Journal:  J Bacteriol       Date:  2011-11       Impact factor: 3.490

5.  Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities.

Authors:  Galarah D Golanbar; Christopher K Lam; Yi-Ming Chu; Carla Cueva; Stephanie W Tan; Isba Silva; H Howard Xu
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

6.  Extrahuman epidemiology of Acinetobacter baumannii in Lebanon.

Authors:  Rayane Rafei; Monzer Hamze; Hélène Pailhoriès; Matthieu Eveillard; Laurent Marsollier; Marie-Laure Joly-Guillou; Fouad Dabboussi; Marie Kempf
Journal:  Appl Environ Microbiol       Date:  2015-01-23       Impact factor: 4.792

7.  Acquisition of a High Diversity of Bacteria during the Hajj Pilgrimage, Including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 Carbapenemase Genes.

Authors:  Thongpan Leangapichart; Philippe Gautret; Karolina Griffiths; Khadidja Belhouchat; Ziad Memish; Didier Raoult; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

8.  Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.

Authors:  Azam F Tayabali; Kathy C Nguyen; Philip S Shwed; Jennifer Crosthwait; Gordon Coleman; Verner L Seligy
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

9.  The complete genome and phenome of a community-acquired Acinetobacter baumannii.

Authors:  Daniel N Farrugia; Liam D H Elbourne; Karl A Hassan; Bart A Eijkelkamp; Sasha G Tetu; Melissa H Brown; Bhumika S Shah; Anton Y Peleg; Bridget C Mabbutt; Ian T Paulsen
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns.

Authors:  Erika R Vlieghe; Thong Phe; Birgit De Smet; Heng Chhun Veng; Chun Kham; Kruy Lim; Olivier Koole; Lut Lynen; Willy E Peetermans; Jan A Jacobs
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.